Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
245.00    0.00 (0.00%)
Bid:
245.00
Ask:
250.00
Spread: 5.00 (2.041%)
Market Cap: £142.92m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Trading Update

1 May 2026 07:00

RNS Number : 6971C
MJ Gleeson PLC
01 May 2026
 

 

MJ Gleeson plc 

("MJ Gleeson" or the "Group") 

 

Trading Update

MJ Gleeson plc is providing a trading update covering the 11 weeks to 24 April 2026 ("the Period").

 

Gleeson Homes

 

Trading

 

Gleeson Homes has experienced resilient trading through the period since 11 February, when the Group announced its H1 results. Net reservation rates for the 11 weeks to 24 April were 0.88 per site per week (0.59 excluding bulk reservations) compared to 0.86 per site per week (0.64 excluding bulk reservations) during the same period last year.

 

There has been modest build cost inflation since the start of the calendar year whilst underlying selling prices on open-market and partnership sales have been broadly stable. Protecting margin continues to be a priority.

 

Restructuring & legacy site cost provisions

 

Following the successful implementation of Project Transform, we continue to seek opportunities to improve the business, sharpening efficiency, mitigating overhead costs and focusing our investment into those regions and locations where we see optimal prospects for controlled growth.

 

From 1 July, the Yorkshire East region will be integrated into Yorkshire South and West. The creation of one Yorkshire region, and reallocation of certain sites into the Midlands region, will improve the efficiency of those regions, refocus our investment into higher return land opportunities and generate annualised regional overhead savings of £0.9m. The related costs are estimated at up to £3.1 million, comprising cash restructure costs of £0.3m and the non-cash impairment of certain conditionally purchased land assets of between £1.5m and £2.8m, and will be recognised as an exceptional item in the full-year accounts.

 

Our new management teams have identified issues on previously completed legacy developments, mainly in Yorkshire, which require rectification in order to achieve adoption of the roads (and other statutory services) by the relevant Local Authorities. As we work through these issues we expect to establish cost provisions in the current financial year estimated at between £5.2 million and £7.1 million, for remedial works to be undertaken over the next three to four years. It is expected that Adjusted results1 for the current financial year will exclude these legacy site provisions.

 

Gleeson Land

 

Gleeson Land continues to progress the sale of five sites including one site which represents approximately 50% of total plots forecast to be sold during the year. In respect of that project, we have made good progress on the required technical solution, which has now been accepted by the highways authority. The timing of conclusion of the sale is subject to formal technical approval. We will provide an update when we are clearer on that timing.

FY2026 outturn

 

With greater visibility across Gleeson Homes' Spring selling season and subject to Gleeson Land completing its major land sale, the Board expects that Adjusted Group Profit before Tax1 for the year ending 30 June 2026 will be in line with market consensus2.

 

Graham Prothero, CEO, commented:

 

"We are pleased that Gleeson Homes' trading performance has been resilient in an uncertain market environment.

 

"Whilst it is frustrating that further work is required on a number of legacy sites, I am pleased with the determination of our new management teams to identify and rectify legacy issues which now allows Gleeson Homes to look forward with confidence.

 

"It is too early to forecast the degree to which the crisis in the Middle East will impact customer confidence, mortgage affordability and build cost inflation over the coming months. We have recently seen some softening in footfall and reservations, and limited increases in the cost of some materials. This, together with ongoing challenges with planning and site viability, prompts even higher than usual caution in how we manage the business, including land investment decisions, into the next financial year.

 

"However, following the successful implementation of Project Transform, which has driven a greater focus on operational effectiveness and efficiency, the business as a whole is now in a much stronger position to manage through this period of uncertainty and capitalise on the significant opportunities we see ahead when the market returns to growth."

 

Graham Prothero, CEO, and Stefan Allanson, CFO, will host a conference call at 08:00 this morning. Institutional investors and analysts can register at mjgleeson@stoneway.co their interest in joining the call.

 

1 Adjusted Operating Profit and Adjusted Group Profit Before Tax will be determined in accordance with the Group's accounting policies and, while the classification of these costs remain under review, Adjusted Operating Profit and Adjusted Group Profit Before Tax are currently expected to exclude exceptional items and the additional completed site cost provisions which, in total, amount to between £7.0m and £10.2m. These adjustments are in addition to £0.3m exceptional items recognised in the interim results and the estimated £4.5m exceptional costs of restructuring the Greater Manchester Merseyside region announced in February 2026.

2 The company compiled consensus of Group Profit Before Tax and Exceptional items for the year ending 30 June 2026 is £18.2m with a range of £12.9m to £20.5m and can be found at: https://www.mjgleesonplc.com/investors/analyst-coverage/

 

Enquiries:

 

MJ Gleeson plc +44 1142 612 900

Graham Prothero, Chief Executive Officer

Stefan Allanson, Chief Financial Officer

 

Stoneway (Financial PR) mjgleeson@stoneway.co

Mark Garraway +44 7771 860938

Kim Looringh-van Beeck +44 20 3422 0208

 

Singer Capital Markets (Joint broker) +44 20 7496 3000

Shaun Dobson

Charles Leigh-Pemberton

 

Peel Hunt (Joint broker) +44 20 7418 8900

Ed Allsopp

Tom Graham

 

 

The information contained within this announcement was previously deemed by the Company to constitute inside information as stipulated by Market Abuse Regulation (EU) No 596/2014 ("EU MAR") and the retained UK law version of EU MAR pursuant to the Market Abuse (Amendment) (EU Exit) Regulations 2019 (SI 2019/310) ("UK MAR"). With the publication of this announcement via a Regulatory Information Service, this information is now considered to be in the public domain. For the purposes of UK MAR, the person responsible for arranging for the release of this information on behalf of MJ Gleeson plc is Stefan Allanson, Chief Financial Officer

LEI: 21380064K7N2W7FD6434

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTWPUBPCUPQPPU
Date   Source Headline
7th Jan 20217:00 amRNSDirector/PDMR Shareholding
31st Dec 20207:00 amRNSTotal Voting Rights
9th Dec 20205:54 pmRNSDirector/PDMR Shareholding
3rd Dec 20201:44 pmRNSResult of AGM
3rd Dec 20207:00 amRNSAGM Statement
30th Nov 20207:00 amRNSTotal Voting Rights
19th Nov 20209:50 amRNSDirector/PDMR Shareholding
10th Nov 20206:15 pmRNSDirector/PDMR Shareholding
3rd Nov 20207:00 amRNSNotice of AGM
30th Oct 20207:00 amRNSTotal Voting Rights
22nd Oct 20203:01 pmRNSDirector/PDMR Shareholding
9th Oct 20202:25 pmRNSDirector/PDMR Shareholding
30th Sep 20207:00 amRNSTotal Voting Rights
25th Sep 20209:48 amRNSPerformance Share Plan Award to Directors/PDMRs
16th Sep 202012:46 pmRNSDirector/PDMR Shareholding
14th Sep 20207:00 amRNSFinal Results
9th Sep 20201:18 pmRNSDirector/PDMR Shareholding
28th Aug 20207:00 amRNSTotal Voting Rights
6th Aug 20205:29 pmRNSDirector/PDMR Shareholding
31st Jul 20207:00 amRNSTotal Voting Rights
17th Jul 20207:00 amRNSLong Term Incentive Plan Award
9th Jul 20207:00 amRNSTrading Update
8th Jul 20209:42 amRNSDirector/PDMR Shareholding
2nd Jul 202012:07 pmRNSSecond Price Monitoring Extn
2nd Jul 202012:02 pmRNSPrice Monitoring Extension
30th Jun 20207:00 amRNSTotal Voting Rights
15th Jun 20207:00 amRNSTrading Update
9th Jun 202010:29 amRNSDirector/PDMR Shareholding
29th May 20207:00 amRNSTotal Voting Rights
22nd May 20207:00 amRNSCommittee Appointments
18th May 202012:07 pmRNSSecond Price Monitoring Extn
18th May 202012:02 pmRNSPrice Monitoring Extension
14th May 20207:00 amRNSReopening of sites and sales offices
7th May 20209:52 amRNSDirector/PDMR Shareholding
30th Apr 20207:00 amRNSTotal Voting Rights
28th Apr 20205:24 pmRNSDisclosure of Rights attached to Listed Securities
28th Apr 20204:42 pmRNSDirector/PDMR Shareholding
9th Apr 20201:32 pmRNSNotification of Transactions by Directors / PCA
8th Apr 20206:14 pmRNSDirector/PDMR Shareholding
8th Apr 20201:16 pmRNSResults of Placing
8th Apr 20207:00 amRNSDirector/PDMR Shareholding
8th Apr 20207:00 amRNSProposed Placing of New Shares
6th Apr 20207:00 amRNSCovid-19 Update
1st Apr 20204:41 pmRNSSecond Price Monitoring Extn
1st Apr 20204:36 pmRNSPrice Monitoring Extension
1st Apr 202012:07 pmRNSSecond Price Monitoring Extn
1st Apr 202012:02 pmRNSPrice Monitoring Extension
31st Mar 20207:00 amRNSTotal Voting Rights
30th Mar 20204:13 pmRNSCompany Secretary Change
25th Mar 20204:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.